Academic Journal

Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies

التفاصيل البيبلوغرافية
العنوان: Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies
المؤلفون: Amir Taldaev, Roman Terekhov, Ilya Nikitin, Elizaveta Melnik, Vera Kuzina, Mikhail Klochko, Igor Reshetov, Artem Shiryaev, Victor Loschenov, Galina Ramenskaya
المصدر: Frontiers in Pharmacology, Vol 14 (2023)
بيانات النشر: Frontiers Media S.A., 2023.
سنة النشر: 2023
المجموعة: LCC:Therapeutics. Pharmacology
مصطلحات موضوعية: methylene blue, cancer, tumor, photodynamic therapy, nanopharmaceutics, systematic review, Therapeutics. Pharmacology, RM1-950
الوصف: Background: Methylene blue has a long history of clinical application. Thanks to phenothiazine chromophore, it has potential in photodynamic anticancer therapy. In spite of the growing body of literature that has evaluated the action of this dye on different types of cancer, the systematic understanding of this problem is still lacking. Therefore, this systematic review was performed to study the efficacy of methylene blue in photodynamic anticancer therapy.Methods: This systematic review was carried out in accordance with the PRISMA guidelines, and the study protocol was registered in PROSPERO (CRD42022368738). Articles for the systematic review were identified through the PubMed database. SYRCLE’s risk of bias tool was used to assess the studies. The results of systematic analysis are presented as narrative synthesis.Results: Ten studies met the inclusion criteria and these full texts were reviewed. In the selected articles, the dosage of dye infusion ranged from 0.04 to 24.12 mg/kg. The effectiveness of photodynamic therapy with methylene blue against different types of cancer was confirmed by a decrease in tumor sizes in seven articles.Conclusion: The results of the systematic review support the suggestions that photodynamic therapy with methylene blue helps against different types of cancer, including colorectal tumor, carcinoma, and melanoma. In cases of nanopharmaceutics use, a considerable increase of anticancer therapy effectiveness was observed. The further research into methylene blue in photodynamic anticancer therapy is needed.Systematic Review Registration: (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=368738), identifier (CRD42022368738).
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1663-9812
Relation: https://www.frontiersin.org/articles/10.3389/fphar.2023.1264961/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2023.1264961
URL الوصول: https://doaj.org/article/9fd0195c32324f6897b29fca8a2cd68e
رقم الانضمام: edsdoj.9fd0195c32324f6897b29fca8a2cd68e
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:16639812
DOI:10.3389/fphar.2023.1264961